摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

D-色氨酸苄酯盐酸盐 | 22839-16-3

中文名称
D-色氨酸苄酯盐酸盐
中文别名
D-色氨酸苯甲酯盐酸盐;D -色氨酸苄酯盐酸盐
英文名称
D-Trp-OBzl.HCl
英文别名
H-D-Trp-OBzl.HCl;benzyl (2R)-2-amino-3-(1H-indol-3-yl)propanoate;hydrochloride
D-色氨酸苄酯盐酸盐化学式
CAS
22839-16-3
化学式
C18H18N2O2*ClH
mdl
——
分子量
330.814
InChiKey
DOKDMGOWZOTZRA-PKLMIRHRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    215 °C
  • 稳定性/保质期:
    <b> <p></p> </b>

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    68.1
  • 氢给体数:
    3
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:ead80cd0d7af49b85d2c46d9534db8c9
查看
D-Tryptophan Benzyl Ester Hydrochloride Revision number: 5
SAFETY DATA SHEET

Section 1. IDENTIFICATION
Product name: D-Tryptophan Benzyl Ester Hydrochloride

Revision number: 5

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not classified
Not classified
HEALTH HAZARDS
ENVIRONMENTAL HAZARDS Not classified
GHS label elements, including precautionary statements
Pictograms or hazard symbols None
No signal word
Signal word
Hazard statements None
None
Precautionary statements:

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: D-Tryptophan Benzyl Ester Hydrochloride
Percent: >98.0%(N)
CAS Number: 22839-16-3
Synonyms: H-D-Trp-OBzl·HCl
Chemical Formula: C18H18N2O2·HCl

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards arising Take care as it may decompose upon combustion or in high temperatures to
from the chemical: generate poisonous fume.
D-Tryptophan Benzyl Ester Hydrochloride

Section 5. FIRE-FIGHTING MEASURES
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

Section 6. ACCIDENTAL RELEASE MEASURES
Use personal protective equipment. Keep people away from and upwind of spill/leak.
Personal precautions,
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Handling is performed in a well ventilated place. Wear suitable protective equipment.
Technical measures:
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Storage conditions: Keep container tightly closed. Store in a cool and dark place.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Comply with laws.

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Install a closed system or local exhaust as possible so that workers should not be
Engineering controls:
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: Crystal- Powder
Colour: White - Very pale yellow
Odour: No data available
pH: No data available
Melting point/freezing point:215°C
No data available
Boiling point/range:
Flash point: No data available
Flammability or explosive
limits:
No data available
Lower:
Upper: No data available
No data available
Relative density:
Solubility(ies):
No data available
[Water]
[Other solvents] No data available
D-Tryptophan Benzyl Ester Hydrochloride

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx), Hydrogen chloride
products:

Section 11. TOXICOLOGICAL INFORMATION
No data available
Acute Toxicity:
Skin corrosion/irritation: No data available
No data available
Serious eye
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
IARC = No data available
NTP = No data available
No data available
Reproductive toxicity:

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
No data available
Fish:
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
Log Pow: No data available
No data available
Soil adsorption (Koc):
Henry's Law No data available
constant(PaM3/mol):

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
Not listed
UN-No:

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.
D-Tryptophan Benzyl Ester Hydrochloride


SECTION 16 - ADDITIONAL INFORMATION
N/A


制备方法与用途

合成制备方法
用途

反应信息

  • 作为反应物:
    描述:
    D-色氨酸苄酯盐酸盐 在 palladium on activated charcoal 氢气 、 sodium cyanoborohydride 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 作用下, 以 甲醇二氯甲烷溶剂黄146乙腈 为溶剂, 25.0 ℃ 、379.21 kPa 条件下, 生成 (3R,6S,8aS)-3-(1H-Indol-3-ylmethyl)-4-oxo-hexahydro-pyrrolo[1,2-a]pyrazine-2,6-dicarboxylic acid 2-tert-butyl ester 6-methyl ester
    参考文献:
    名称:
    Chan, Ming Fai; Raju, Bore G.; Kois, Adam, Heterocycles, 1999, vol. 51, # 1, p. 5 - 8
    摘要:
    DOI:
  • 作为产物:
    描述:
    (R)-2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionic acid benzyl ester盐酸 作用下, 以 1,4-二氧六环 为溶剂, 以95%的产率得到D-色氨酸苄酯盐酸盐
    参考文献:
    名称:
    设计结核分枝杆菌CYP121抑制剂的底物片段化。
    摘要:
    必需的结核分枝杆菌(Mtb)酶CYP121的环二肽底物被解构成其组成片段并针对该酶进行筛选。鉴定了许多命中,其中之一表现出意想不到的抑制剂样结合模式。阐明了抑制药效基团,并通过以CYP121底物的结构为指导的合成加工,迅速提高了片段结合亲和力。所得抑制剂与其他Mtb P450相比,具有较低的微摩尔亲和力,良好的预测理化性质和对CYP121的选择性。抑制剂结合模式的光谱表征可深入了解弱氮供体配体对P450血红素的影响,
    DOI:
    10.1002/cmdc.201600248
点击查看最新优质反应信息

文献信息

  • Method of treating tumors
    申请人:Svendsen John Sigurd
    公开号:US09115169B2
    公开(公告)日:2015-08-25
    The invention provides a method of treating tumors by adminstering to a human or animal patient an effective amount of a molecule of 2 to 4 amino acids or equivalent subunits in length, which incorporates a bulky and lipophilic group comprising at least 13 non-hydrogen atoms and containing no more than 2 polar functional groups, in which the bulky and lipophilic group incorporates one or more closed rings of 5 or more non-hydrogen atoms, and in which the molecule further has at least two more cationic than anionic moieties.
    这项发明提供了一种治疗肿瘤的方法,通过向人类或动物患者施用含有2至4个氨基酸或等效亚单位的分子的有效量,该分子包含至少13个非氢原子的庞大和亲脂基团,并且不含有超过2个极性功能团,在这种庞大和亲脂基团中包含了一个或多个由5个或更多个非氢原子组成的闭环,并且该分子还具有至少两个阳离子基团多于阴离子基团。
  • [EN] PRODRUGS OF D-ISOGLUTAMYL-[D/L]-TRYPTOPHAN<br/>[FR] PROMÉDICAMENTS DE D-ISOGLUTAMYL-[D/L]-TRYPTOPHANE
    申请人:APOTEX TECHNOLOGIES INC
    公开号:WO2012129671A1
    公开(公告)日:2012-10-04
    Provided are carboxylic ester derivatives of formula (I), methods of preparing them, and methods for using them. These compounds are prodrugs of D-isoglutamyl-[D/L]-tryptophan. The in vitro bioconversion of some of the prodrugs to the parent drug D-isoglutamyl-D-tryptophan (or thymodepressin) was tested in human hepatocytes and in human blood. In vivo pharmacokinetic studies following oral administration of some of the prodrugs to rats are also reported.
    提供了公式(I)的羧酸酯衍生物,其制备方法以及使用方法。这些化合物是D-异谷氨酰-[D/L]-色氨酸的前药。对一些前药在人类肝细胞和人类血液中转化为母药D-异谷氨酰-D-色氨酸(或胸腺抑制素)的体外生物转化进行了测试。还报告了将一些前药口服给大鼠后的体内药代动力学研究。
  • 氨基酸和氨甲环酸修饰的二酮哌嗪 ,其制备 , 活性和应用
    申请人:首都医科大学
    公开号:CN110551107B
    公开(公告)日:2021-02-12
    本发明公开了下面结构的3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Phe‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪和3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Asn‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪。公开了它们的制备方法和其抗肿瘤作用,阐明了它们在制备抗肿瘤药物中的应用。
  • 氨基酸和氨甲环酸修饰的二酮哌嗪 ,其制备及 应用
    申请人:首都医科大学
    公开号:CN110551109B
    公开(公告)日:2021-02-12
    本发明公开了下面结构的3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Lys‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪和3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Thr‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪。公开了它们的制备方法和其抗肿瘤兼抗转移作用,阐明了它们在制备抗肿瘤兼抗转移药物中的应用。
  • 氨基酸和氨甲环酸修饰的二酮哌嗪 ,其制备和 应用
    申请人:首都医科大学
    公开号:CN110577516B
    公开(公告)日:2021-06-08
    本发明公开了下面结构的3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Gly‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪和3R‑(吲哚‑3‑甲基)‑6R‑[4‑(Gln‑氨甲环酰氨基正丁基)]‑2,5‑二酮哌嗪。公开了它们的制备方法和其抗肿瘤兼抗炎作用,阐明了它们在制备抗肿瘤兼抗炎药物中的应用。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物